What Is Sermorelin? Uses, Benefits, Safety, FDA Status, and Evidence
Medical review note: This article is for educational purposes only and does not provide medical advice. Sermorelin was previously FDA-approved under the brand name Geref, but Geref is discontinued. Compounded sermorelin products are not the same as an FDA-approved currently marketed product and may carry quality, safety, and regulatory risks.
Quick answer
Sermorelin is a synthetic version of growth hormone-releasing hormone, also called GHRH or growth hormone-releasing factor. It stimulates the pituitary gland to release the body’s own growth hormone rather than directly supplying recombinant human growth hormone. Sermorelin was previously FDA-approved as Geref for growth-hormone-related diagnostic and pediatric uses, but Geref is discontinued. The FDA later determined that Geref was not withdrawn for reasons of safety or effectiveness. Today, sermorelin is commonly discussed in anti-aging, wellness, and growth-hormone-optimization clinics, but many of those claims go beyond the strongest evidence. Sermorelin is also prohibited in competitive sport.
Key facts about Sermorelin
| Question | Answer |
|---|---|
| What is sermorelin? | A synthetic growth hormone-releasing hormone analog. |
| Other names | Sermorelin acetate, Geref, GHRH 1-29, growth hormone-releasing factor 1-29. |
| Drug class | Growth hormone-releasing hormone analog / growth hormone secretagogue. |
| Main mechanism | Stimulates the pituitary gland to produce and release endogenous growth hormone. |
| FDA-approved? | Previously approved as Geref, but Geref is discontinued. |
| Current FDA status | No currently marketed FDA-approved sermorelin product identified here. FDA determined Geref was not withdrawn for safety or effectiveness reasons. |
| Main historical uses | Diagnostic evaluation of growth hormone secretion and pediatric growth hormone deficiency-related use. |
| Human evidence level | Moderate historical evidence for pediatric growth-hormone-related use; weaker evidence for adult anti-aging/wellness claims. |
| Common online claims | “Increases HGH,” “anti-aging,” “fat loss,” “muscle recovery,” “better sleep,” “improved body composition.” |
| Sports status | Prohibited by USADA/WADA as a growth hormone-releasing factor. |
| Main safety concern | Hormonal effects, injection reactions, lack of current FDA-approved marketed product, and quality risks from compounded or online products. |
What is sermorelin?
Sermorelin is a synthetic analog of growth hormone-releasing hormone. Growth hormone-releasing hormone is a naturally occurring hormone that signals the pituitary gland to release growth hormone.
The Mayo Clinic drug reference describes sermorelin as a synthetic version of a naturally occurring substance that causes release of growth hormone from the pituitary gland.
Sermorelin is often discussed as an alternative to taking recombinant human growth hormone directly. The distinction is important:
| Therapy type | What it does |
|---|---|
| Sermorelin | Signals the pituitary gland to release endogenous growth hormone. |
| Recombinant human growth hormone | Supplies growth hormone directly. |
| CJC-1295 | A longer-acting GHRH analog, often discussed in peptide clinics. |
| Ipamorelin | A growth hormone secretagogue that works through ghrelin receptor pathways. |
The key distinction:
Sermorelin stimulates the body’s own growth hormone release. It is not the same thing as injecting human growth hormone.
How does sermorelin work?
Sermorelin mimics part of natural GHRH. It binds to GHRH receptors in the pituitary gland and stimulates growth hormone release.
That can increase downstream growth hormone activity and may influence insulin-like growth factor 1, also called IGF-1. This is why sermorelin is often marketed for growth hormone optimization.
But mechanism is not proof.
A proposed hormonal mechanism does not prove that sermorelin reverses aging, builds muscle, burns fat, improves sleep, increases longevity, or improves recovery in healthy adults. The quality of evidence depends on controlled human studies and the specific population being treated.
What is sermorelin used for?
Sermorelin has historical medical use and many broader online claims. These should not be treated the same.
| Use | Evidence level | What is known | What is not known |
|---|---|---|---|
| Pediatric growth hormone deficiency-related use | Historical human evidence | Geref Pediatric was previously FDA-approved for short stature associated with pediatric growth hormone deficiency. | Geref is discontinued and no currently marketed FDA-approved sermorelin product is identified here. |
| Diagnostic evaluation of GH secretion | Historical FDA-approved use | Geref Diagnostic was previously FDA-approved for diagnostic evaluation of growth hormone secretion. | It is no longer commercially available as Geref. |
| Adult growth hormone deficiency | Limited / off-label discussion | Some clinicians discuss sermorelin for adult GH-related concerns. | Strong modern approval-level evidence for broad adult use is lacking. |
| Anti-aging | Weak / unsupported | Often marketed by longevity and wellness clinics. | Aging reversal and longevity benefits are not proven. |
| Fat loss/body composition | Limited / extrapolated | GH/IGF-1 pathways may affect body composition. | Routine use for fat loss in otherwise healthy adults is not well established. |
| Muscle growth/recovery | Weak / extrapolated | Online claims are common. | Performance and recovery claims are not well established and the substance is prohibited in sport. |
| Online sermorelin products | High uncertainty | Some products may be compounded or sold through peptide markets. | Quality, sterility, identity, dosing, and legal status can vary. |
What does the research show?
Human evidence for pediatric growth
Sermorelin has historical human evidence in children with growth hormone deficiency-related growth issues.
A PubMed-indexed study on once-daily subcutaneous growth hormone-releasing hormone therapy reported that Geref accelerated growth in growth hormone-deficient children during the first year of therapy.
This supports sermorelin’s biological role in stimulating growth hormone pathways. It does not automatically support modern anti-aging or wellness claims in healthy adults.
FDA history
Sermorelin was previously approved by FDA under the brand name Geref.
A Federal Register notice states that FDA determined Geref 0.5 mg and 1.0 mg were not withdrawn from sale for reasons of safety or effectiveness.
The FDA medical review for tesamorelin also notes that sermorelin acetate, trade name Geref Diagnostic, had previously been approved as a diagnostic agent for adult growth hormone deficiency, and Geref Pediatric had been approved as treatment for short stature associated with pediatric growth hormone deficiency.
The practical interpretation:
Sermorelin has a real FDA history. It is not a random internet peptide. But the historically approved Geref products are discontinued, and modern compounded sermorelin is not the same as a currently marketed FDA-approved product.
Adult anti-aging and wellness evidence
Adult anti-aging claims are much weaker.
A 2006 review on sermorelin and adult-onset growth hormone insufficiency argued that sermorelin may be useful in age-management contexts. However, this type of review should not be treated the same as large, modern randomized trials proving anti-aging or longevity outcomes.
The practical interpretation:
Sermorelin may raise growth hormone activity in appropriate patients, but broad anti-aging, longevity, and performance claims are not proven.
Evidence summary
| Claim | Evidence verdict | Explanation |
|---|---|---|
| “Sermorelin stimulates growth hormone release.” | Supported | Sermorelin is a GHRH analog that stimulates pituitary growth hormone release. |
| “Sermorelin was FDA-approved.” | Supported historically | Geref was previously FDA-approved, but it is discontinued. |
| “Geref was withdrawn because it was unsafe.” | False / unsupported | FDA determined Geref was not withdrawn for reasons of safety or effectiveness. |
| “Sermorelin treats pediatric growth hormone-related growth issues.” | Historically supported | Geref Pediatric was previously approved for short stature associated with pediatric growth hormone deficiency. |
| “Sermorelin reverses aging.” | Unsupported | Anti-aging and longevity claims are not established by strong clinical evidence. |
| “Sermorelin burns fat and builds muscle in healthy adults.” | Weak / extrapolated | These claims are mostly based on GH biology and clinic marketing, not strong approval-level evidence. |
| “Sermorelin is safer than growth hormone.” | Not proven broadly | It has a different mechanism, but that does not automatically prove superior safety for all users. |
| “Sermorelin is allowed for athletes.” | False | USADA says sermorelin is prohibited in sport. |
| “Compounded sermorelin is the same as Geref.” | Misleading | Geref was an FDA-approved product; compounded products do not undergo the same FDA premarket review. |
Is sermorelin FDA-approved?
Sermorelin was previously FDA-approved under the brand name Geref, but Geref is discontinued.
The Federal Register notice on Geref states that FDA determined Geref was not withdrawn from sale for reasons of safety or effectiveness.
The key distinction:
Sermorelin has historical FDA approval, but there does not appear to be a currently marketed FDA-approved sermorelin product available under Geref. Compounded sermorelin is not the same as a currently marketed FDA-approved drug.
Is sermorelin legal?
Sermorelin’s legal status depends on the product and context.
Prescription and compounding issues are different from online peptide sales. A compounded medication may be prepared by a licensed pharmacy under specific circumstances and with a valid prescription, but compounded drugs are not the same as FDA-approved drugs and are not reviewed by FDA for safety, effectiveness, or quality before marketing in the same way.
The blunt version:
A prescription compounded sermorelin product from a licensed pharmacy is not the same as buying “research use only” sermorelin from an online peptide seller.
Is sermorelin banned in sports?
Yes. Sermorelin is prohibited in sport.
The USADA sermorelin guidance states that sermorelin is prohibited because it can boost endogenous human growth hormone production.
The WADA Prohibited List includes growth hormone-releasing factors, including GHRH and its analogues, under prohibited substances.
For athletes, the answer is simple:
Do not use sermorelin if you are subject to anti-doping rules unless official anti-doping authorities explicitly confirm an allowed therapeutic-use pathway.
Safety and side effects
Sermorelin has real biological activity. It should not be treated like a harmless supplement.
Possible or reported side effects may include:
- Injection-site reactions
- Flushing
- Headache
- Dizziness
- Nausea
- Sleepiness
- Changes in appetite
- Hormonal effects from increased growth hormone activity
- Possible glucose or metabolic effects in susceptible patients
Important safety uncertainties include:
- Quality and sterility of compounded or online products
- Lack of current FDA-approved marketed product controls
- Dosing variability
- Mislabeling or contamination
- Use in people without a diagnosed growth hormone-related condition
- Use for anti-aging or performance claims without strong evidence
- Anti-doping consequences for athletes
A serious evaluation of sermorelin should separate historical FDA-approved Geref from modern compounded or online sermorelin products.
Sermorelin vs similar peptides
| Compound | Category | Main difference |
|---|---|---|
| Sermorelin | GHRH analog | Stimulates pituitary growth hormone release; historically FDA-approved as Geref, now discontinued. |
| CJC-1295 | GHRH analog | Longer-acting GHRH analog, often discussed in peptide clinics; not the same as sermorelin. |
| Ipamorelin | Growth hormone secretagogue | Stimulates GH through ghrelin receptor pathways, not GHRH receptor pathways. |
| Tesamorelin | GHRH analog | FDA-approved as Egrifta products for reducing excess abdominal fat in adults with HIV and lipodystrophy. |
| Human growth hormone | Recombinant hormone | Supplies growth hormone directly rather than stimulating the pituitary. |
| BPC-157 | Experimental repair peptide | Not a growth-hormone-related peptide. |
The key distinction:
Sermorelin is a growth hormone-releasing hormone analog. It belongs in the growth-hormone secretagogue category, not the tissue-repair peptide or GLP-1 metabolic-drug category.
Why is sermorelin sold as “research use only”?
Some online sellers use “research use only” language to sell sermorelin outside normal prescription-drug channels.
That label is not a trust signal.
A serious reader should understand this distinction:
| Product type | What it means |
|---|---|
| Geref | Previously FDA-approved sermorelin product, now discontinued. |
| Compounded sermorelin | May be prepared under specific pharmacy-compounding rules, but is not the same as a currently marketed FDA-approved product. |
| Research-use sermorelin | Not an FDA-approved consumer therapeutic product. |
| Online peptide sermorelin | Higher risk for identity, sterility, dosing, and quality problems. |
How to evaluate sermorelin claims online
| Claim | What to verify |
|---|---|
| “FDA-approved sermorelin” | Is the seller referring to historical Geref approval or a currently marketed FDA-approved product? |
| “Compounded sermorelin” | Is there a valid prescription and a licensed pharmacy? |
| “Research use only” | This does not mean safe, approved, or appropriate for human use. |
| “Boosts HGH naturally” | Sermorelin stimulates GH release, but benefits depend on patient population and evidence. |
| “Reverses aging” | Look for hard clinical outcome data, not clinic marketing. |
| “Builds muscle and burns fat” | These claims are often extrapolated from GH biology and may not be proven in healthy adults. |
| “Safe for athletes” | False. USADA says sermorelin is prohibited in sport. |
| “Same as growth hormone” | False. Sermorelin stimulates GH release; recombinant HGH supplies GH directly. |
Bottom line
Sermorelin is a synthetic GHRH analog that stimulates the pituitary gland to release growth hormone. It has a real FDA history because Geref was previously approved, and FDA later determined that Geref was not withdrawn for safety or effectiveness reasons. But Geref is discontinued, and modern compounded or online sermorelin products are not the same as a currently marketed FDA-approved drug.
The most defensible conclusion is:
Sermorelin has legitimate historical medical use and a clear growth-hormone-releasing mechanism, but many modern anti-aging, wellness, body-composition, and performance claims go beyond the strongest evidence. Athletes should avoid it because sermorelin is prohibited in sport.
FAQ
What is sermorelin?
Sermorelin is a synthetic growth hormone-releasing hormone analog that stimulates the pituitary gland to release growth hormone.
What does sermorelin do?
Sermorelin signals the pituitary gland to produce and release endogenous growth hormone. It does not directly supply recombinant human growth hormone.
Is sermorelin FDA-approved?
Sermorelin was previously FDA-approved as Geref, but Geref is discontinued. FDA determined that Geref was not withdrawn for reasons of safety or effectiveness.
Is sermorelin still available?
Geref is discontinued. Sermorelin may be available through some compounding channels, but compounded sermorelin is not the same as a currently marketed FDA-approved product.
Is sermorelin the same as HGH?
No. Sermorelin stimulates the pituitary gland to release growth hormone. Recombinant human growth hormone supplies growth hormone directly.
Is sermorelin the same as CJC-1295?
No. Both are GHRH-related peptides, but CJC-1295 is a longer-acting analog and is not the same substance as sermorelin.
Does sermorelin work for anti-aging?
Anti-aging claims are not strongly proven. Sermorelin can stimulate growth hormone release, but that does not prove it reverses aging or improves longevity.
Is sermorelin safe?
Sermorelin has historical medical use, but it is biologically active and can cause side effects. Modern compounded or online products may carry additional quality, sterility, dosing, and regulatory risks.
Is sermorelin banned in sports?
Yes. USADA says sermorelin is prohibited in sport because it can increase endogenous human growth hormone production.
What is the biggest risk with sermorelin?
The biggest risks are using it for unsupported anti-aging or performance claims, using it without medical supervision, and buying online or compounded products that are not equivalent to a currently marketed FDA-approved drug.
Sources
- Federal Register: Determination That Geref Was Not Withdrawn for Safety or Effectiveness
- FDA: Geref Approval Document
- FDA Medical Review: Prior Approval History of Sermorelin/Geref
- Mayo Clinic: Sermorelin Injection Description
- PubMed: Once Daily Subcutaneous Growth Hormone-Releasing Hormone Therapy
- PMC: Sermorelin and Adult-Onset Growth Hormone Insufficiency Review
- USADA: What Should Athletes Know About Sermorelin?
- WADA: Prohibited List
- FDA Ginas: Sermorelin Substance Record
Frequently asked questions
What is sermorelin?
Sermorelin is a synthetic growth hormone-releasing hormone analog that stimulates the pituitary gland to release growth hormone.
Is sermorelin FDA-approved?
Sermorelin was previously FDA-approved as Geref, but Geref is discontinued. FDA determined that Geref was not withdrawn for reasons of safety or effectiveness.
Is sermorelin the same as HGH?
No. Sermorelin stimulates the pituitary gland to release growth hormone. Recombinant human growth hormone supplies growth hormone directly.
Does sermorelin work for anti-aging?
Anti-aging claims are not strongly proven. Sermorelin can stimulate growth hormone release, but that does not prove it reverses aging or improves longevity.
Is sermorelin banned in sports?
Yes. USADA says sermorelin is prohibited in sport because it can increase endogenous human growth hormone production.
What is the biggest risk with sermorelin?
The biggest risks are using it for unsupported anti-aging or performance claims, using it without medical supervision, and buying online or compounded products that are not equivalent to a currently marketed FDA-approved drug.
Sources
- [1]
- [2]FDA: Geref Approval Document
Regulatory
- [3]
- [4]Mayo Clinic: Sermorelin Injection Description
Medical Reference
- [5]
- [6]
- [7]
- [8]WADA: Prohibited List
Anti Doping
- [9]FDA Ginas: Sermorelin Substance Record
Substance Record
Last updated May 9, 2026